Evidence map›Paper›PMID 29843406›Full record

ReviewInternational journal of molecular sciences2018

Therapeutics for Inflammatory-Related Diseases Based on Plasmon-Activated Water: A Review.

Chih-Ping Yang, Yu-Chuan Liu

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07659236 (The Potential Application of Plasma-Activated Water in Fibromyalgia Patients), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07659236 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Potential Application of Plasma-Activated Water in Fibromyalgia Patients

TypeinterventionalSponsorTaipei Medical UniversityRan2024 to 2026Enrolled80ConditionsSafety and Potential Symptom Improvement Effects of Long Term Consumption of Plasma Activated Water in Fibromyalgia PatientsArmsPlasma-Activated Water, Placebo
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Functional Plasmon-Activated Water IncreasesInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chih-Ping YangDepartment of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, 250 Wuxing St., Taipei 11031, Taiwan. d119099007@tmu.edu.tw.
Yu-Chuan LiuDepartment of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, 250 Wuxing St., Taipei 11031, Taiwan. liuyc@tmu.edu.tw.ORCID 0000-0003-2111-8991
Taipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is recognized that the properties of liquid water can be markedly different from those of bulk one when it is in contact with hydrophobic surfaces or is confined in nano-environments. Because our knowledge regarding water structure on the molecular level of dynamic equilibrium within a picosecond time scale is far from completeness all of water's conventionally known properties are based on inert "bulk liquid water" with a tetrahedral hydrogen-bonded structure. Actually, the strength of water's hydrogen bonds (HBs) decides its properties and activities. In this review, an innovative idea on preparation of metastable plasmon-activated water (PAW) with intrinsically reduced HBs, by letting deionized (DI) water flow through gold-supported nanoparticles (AuNPs) under resonant illumination at room temperature, is reported. Compared to DI water, the created stable PAW can scavenge free hydroxyl and 2,2-diphenyl-1-picrylhydrazyl radicals and effectively reduce NO release from lipopolysaccharide-induced inflammatory cells. Moreover, PAW can dramatically induce a major antioxidative

Indexed as

Surface Plasmon ResonanceAnimalsAnti-Inflammatory AgentsAntioxidantsBiphenyl CompoundsDisease Models, AnimalFibroblastsGene ExpressionGoldHumansHydrogen BondingLipopolysaccharidesLung NeoplasmsNanoparticlesNF-E2-Related Factor 2Nitric Oxide1,1-diphenyl-2-picrylhydrazylAnti-Inflammatory AgentsAntioxidantsBiphenyl CompoundsGoldLipopolysaccharidesNFE2L2 protein, humanNF-E2-Related Factor 2Nitric OxidePicratesWateranimal disease modelanti-inflammatorygold nanoparticlesmedicineplasmon-activated water

Identifiers

PMID29843406
PMCPMC6032129
OpenAlexW2803234798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.